Trials / Completed
CompletedNCT04411849
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening Among Women in Appalachia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 802 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- Female
- Age
- 30 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.
Detailed description
PRIMARY OBJECTIVES: Determine the effectiveness of the intervention in increasing cervical cancer screening. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive the HPV self-testing intervention consisting of mailed HPV self-test devices. Participants also receive an information about cervical cancer. Participants who do not return their self-test within a few weeks receive telephone-based patient navigation. GROUP II: Participants receive usual care consisting of a reminder letter to get a clinic-based cervical cancer screening test and information about cervical cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Best Practice | Receive usual care |
| PROCEDURE | HPV Self-Collection | Receive HPV self-testing intervention |
| OTHER | Informational Intervention | Receive information about cervical cancer |
| BEHAVIORAL | Patient Navigation Program | Receive telephone-based patient navigation |
Timeline
- Start date
- 2021-08-27
- Primary completion
- 2024-06-11
- Completion
- 2024-06-11
- First posted
- 2020-06-02
- Last updated
- 2025-09-10
- Results posted
- 2024-12-04
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04411849. Inclusion in this directory is not an endorsement.